HIF-1alpha partners with FoxA2, a neuroendocrine-specific transcription factor, to promote tumorigenesis
- PMID: 20609346
- PMCID: PMC3144028
- DOI: 10.1016/j.ccr.2010.06.007
HIF-1alpha partners with FoxA2, a neuroendocrine-specific transcription factor, to promote tumorigenesis
Abstract
In this issue of Cancer Cell, Qi et al. report a novel mechanism by which HIF-1alpha synergizes with a tissue-specific transcription factor, FoxA2, to promote a transcriptional program that supports prostate tumor formation and progression.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Figures
Comment on
-
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.Cancer Cell. 2010 Jul 13;18(1):23-38. doi: 10.1016/j.ccr.2010.05.024. Cancer Cell. 2010. PMID: 20609350 Free PMC article.
References
-
- Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G, Kloog Y. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res. 2005;65:999–1006. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
